Eliseo Oreste Salinas - 10 Feb 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Reporting relationship: Chief Res. & Develop Officer
Issuer ticker: PASG
Reported as of: 10 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Feb 2022, 16:21:20 UTC
Source filing: View source filing
Reporting owner signature: /s/ Edgar Cale, Attorney-in Fact

Key filing fact

Eliseo Oreste Salinas filed Form 4 for Passage BIO, Inc. (PASG) on 14 Feb 2022.

Key facts

This page summarizes Eliseo Oreste Salinas's Form 4 filing for Passage BIO, Inc. (PASG).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Feb 2022, 16:21.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PASG transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +157,500
Change %
Price: $0.000000
Shares after: 157,500
Date: 10 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 157,500
Exercise price: $4.52
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.